Curcumin Versus Ibuprofen for Exercise-Induced Muscle Damage in Physically Active Women (CURACTIVE)
Comparative Efficacy of Oral Curcumin Supplementation Versus Ibuprofen on Exercise-Induced Muscle Damage, Inflammation, Oxidative Stress, and Sports Performance in Physically Active Women: A Randomized Double-Blind Placebo-Controlled Trial
xercise-induced muscle damage (EIMD) is a common consequence of unaccustomed or high-intensity exercise and is characterized by muscle soreness, impaired physical performance, inflammation, oxidative stress, and increased circulating biomarkers of muscle damage. Non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, are frequently used to alleviate these symptoms, although their repeated use may be associated with adverse effects. Curcumin, a natural polyphenol with antioxidant and anti-inflammatory properties, has emerged as a potential nutritional strategy to support post-exercise recovery.
This randomized, double-blind, placebo-controlled trial aims to compare the effects of oral curcumin supplementation and ibuprofen administration on exercise-induced muscle damage in physically active women. The study evaluates clinical outcomes, physical performance, biomarkers of muscle damage, inflammation, oxidative stress, and other health-related biomarkers to determine whether curcumin may represent a safe and effective nutritional alternative for promoting recovery after eccentric exercise.
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
상세 설명
Exercise-induced muscle damage (EIMD) following eccentric exercise is characterized by structural disruption of skeletal muscle fibers accompanied by transient inflammation, oxidative stress, delayed-onset muscle soreness, and impaired physical performance. Although these responses are considered part of the normal adaptive process, excessive muscle damage may delay recovery and impair subsequent training or competition.
Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used by athletes to reduce post-exercise pain and inflammation. However, repeated NSAID use has been associated with gastrointestinal, renal, and cardiovascular adverse effects, highlighting the need for safe nutritional alternatives capable of supporting recovery without interfering with physiological adaptation.
Curcumin, the principal bioactive polyphenol derived from Curcuma longa, exhibits antioxidant, anti-inflammatory, and cytoprotective properties through modulation of multiple molecular pathways involved in redox homeostasis and inflammatory signaling. Experimental and clinical studies suggest that curcumin may attenuate exercise-induced muscle damage by reducing oxidative stress, inflammatory responses, and muscle soreness, although evidence remains inconsistent and direct comparisons with NSAIDs are scarce.
The objective of this randomized, double-blind, placebo-controlled trial is to compare the efficacy of oral curcumin supplementation with ibuprofen and placebo in physically active women following eccentric exercise. The study evaluates clinical recovery, physical performance, biomarkers of muscle damage, inflammatory and oxidative stress biomarkers, and additional health-related biomarkers in order to characterize the physiological effects of curcumin supplementation and determine its potential role as a nutritional strategy for exercise recovery.
연구 유형
연구 유형
등록 (실제)
등록
단계
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
-
Soria, 스페인, 42004
- University Campus of Soria
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
- 성인
건강한 자원 봉사자를 받아들입니다
설명
Inclusion Criteria:
Healthy physically active women. Age within the predefined study range. Regular participation in physical activity for at least 6 months before enrollment.
Ability to perform the eccentric exercise protocol. Written informed consent provided before participation.
Exclusion Criteria:
Current musculoskeletal injury or pain affecting exercise performance. History of cardiovascular, metabolic, neurological, renal, hepatic, or inflammatory disease.
Pregnancy or breastfeeding. Current use of anti-inflammatory drugs, antioxidant supplements, or other nutritional supplements that could interfere with study outcomes.
Known allergy or intolerance to curcumin, turmeric, ibuprofen, or study ingredients.
Smoking or excessive alcohol consumption. Participation in another clinical trial during the study period. Any condition considered by the investigators to compromise participant safety or protocol compliance.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 삼루타
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
실험적: Curcumin
Participants received oral curcumin supplementation according to the study protocol before and following the eccentric exercise protocol.
Clinical recovery, physical performance, muscle damage, inflammatory, oxidative stress, antioxidant defense, and other health-related biomarkers were evaluated during the recovery period.
|
Participants received oral curcumin supplementation according to the study protocol before and after the eccentric exercise protocol.
Curcumin was administered at the predefined dose and duration specified in the protocol.
The intervention aimed to evaluate its effects on exercise-induced muscle damage, inflammation, oxidative stress, antioxidant defense, physical performance, and recovery in physically active women.
다른 이름들:
|
|
활성 비교기: Ibuprofen
articipants received oral ibuprofen according to the study protocol before and following the eccentric exercise protocol.
Clinical recovery, physical performance, muscle damage, inflammatory, oxidative stress, antioxidant defense, and other health-related biomarkers were evaluated during the recovery period.
|
Participants received oral ibuprofen according to the study protocol before and after the eccentric exercise protocol.
Ibuprofen was administered at the predefined dose and duration specified in the protocol and served as the active comparator for evaluating recovery following exercise-induced muscle damage.
|
|
위약 비교기: Placebo
Participants received placebo capsules identical in appearance to the active interventions according to the study protocol before and following the eccentric exercise protocol.
Clinical recovery, physical performance, muscle damage, inflammatory, oxidative stress, antioxidant defense, and other health-related biomarkers were evaluated during the recovery period.
|
Participants received placebo capsules identical in appearance, packaging, and administration schedule to the active interventions.
The placebo contained inert ingredients and was administered according to the study protocol before and after the eccentric exercise protocol.
|
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Exercise-induced muscle damage
기간: Baseline and during the 72-hour recovery period following eccentric exercise.
|
Exercise-induced muscle damage assessed using clinical outcomes and biochemical biomarkers following eccentric exercise to compare the effects of oral curcumin supplementation, ibuprofen, and placebo in physically active women.
|
Baseline and during the 72-hour recovery period following eccentric exercise.
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Creatine kinase (CK)
기간: Baseline and during the 48-hour recovery period following eccentric exercise.
|
Changes in serum creatine kinase concentration as a biomarker of exercise-induced skeletal muscle damage following eccentric exercise.
|
Baseline and during the 48-hour recovery period following eccentric exercise.
|
|
Lactate dehydrogenase (LDH)
기간: Baseline and during the 48-hour recovery period following eccentric exercise.
|
Changes in serum lactate dehydrogenase concentration as an indicator of muscle membrane disruption and tissue damage.
|
Baseline and during the 48-hour recovery period following eccentric exercise.
|
|
Aspartate aminotransferase (AST)
기간: Baseline and during the 48-hour recovery period following eccentric exercise.
|
Changes in serum aspartate aminotransferase concentration as an indirect biomarker of exercise-induced muscle tissue damage.
|
Baseline and during the 48-hour recovery period following eccentric exercise.
|
|
Alanine aminotransferase (ALT)
기간: Baseline and during the 48-hour recovery period following eccentric exercise.
|
Changes in serum alanine aminotransferase concentration following eccentric exercise.
|
Baseline and during the 48-hour recovery period following eccentric exercise.
|
|
Alkaline phosphatase (ALP)
기간: Baseline and during the 48-hour recovery period following eccentric exercise.
|
Changes in serum alkaline phosphatase concentration following eccentric exercise.
|
Baseline and during the 48-hour recovery period following eccentric exercise.
|
|
Interleukin-6 (IL-6)
기간: Baseline and during the 48-hour recovery period following eccentric exercise.
|
Changes in circulating interleukin-6 concentration as a biomarker of the inflammatory response to exercise-induced muscle damage.
|
Baseline and during the 48-hour recovery period following eccentric exercise.
|
|
C-reactive protein (CRP)
기간: Baseline and during the 48-hour recovery period following eccentric exercise.
|
Changes in serum C-reactive protein concentration as a marker of systemic inflammation following eccentric exercise.
|
Baseline and during the 48-hour recovery period following eccentric exercise.
|
|
Malondialdehyde (MDA)
기간: Baseline and during the 48-hour recovery period following eccentric exercise.
|
Changes in plasma malondialdehyde concentration as a biomarker of lipid peroxidation and oxidative stress.
|
Baseline and during the 48-hour recovery period following eccentric exercise.
|
|
Superoxide dismutase (SOD)
기간: Baseline and during the 48-hour recovery period following eccentric exercise.
|
Changes in superoxide dismutase activity as an indicator of endogenous antioxidant defense.
|
Baseline and during the 48-hour recovery period following eccentric exercise.
|
|
Catalase (CAT)
기간: Baseline and during the 48-hour recovery period following eccentric exercise.
|
Changes in catalase activity as a marker of antioxidant defense following eccentric exercise.
|
Baseline and during the 48-hour recovery period following eccentric exercise.
|
|
Delayed-onset muscle soreness (DOMS)
기간: Baseline and during the 48-hour recovery period following eccentric exercise.
|
Changes in perceived muscle soreness assessed using a validated visual analogue scale following eccentric exercise.
|
Baseline and during the 48-hour recovery period following eccentric exercise.
|
|
Countermovement jump (CMJ)
기간: Baseline and during the 48-hour recovery period following eccentric exercise.
|
Changes in countermovement jump performance as a measure of lower-limb neuromuscular function and exercise recovery.
|
Baseline and during the 48-hour recovery period following eccentric exercise.
|
|
Thigh circumference
기간: Baseline and during the 48-hour recovery period following eccentric exercise.
|
Changes in thigh circumference as an indirect indicator of exercise-induced muscle swelling.
|
Baseline and during the 48-hour recovery period following eccentric exercise.
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
연구 시작
기본 완료 (실제)
기본 완료
연구 완료 (실제)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
키워드
추가 관련 MeSH 약관
기타 연구 ID 번호
기타 연구 ID 번호
- DFL-CURC-2025-01
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
IPD 공유 기간
IPD 공유 액세스 기준
IPD 공유 지원 정보 유형
- 연구_프로토콜
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .